At BeiGene, we are developing cancer treatments that have the potential to be best-in-class monotherapies, and core components of innovative combination treatments. We have successfully built a talented and experienced research and development team, and are interested in collaborations with other complementary organizations.

We are committed to partnering with biotech and pharmaceutical companies around the world to jointly discover and develop innovative products that will bring meaningful cures to cancer patients.

Currently we are engaged in partnering/in-licensing discussions related to a number of programs. If you would like additional information on partnering with BeiGene, please contact our business development team at bd@beigene.com